3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
67
Neoplasm Metastasis
6
Prostatic Neoplasms, Castration-Resistant
4
Metastatic Castration-resistant Prostate Cancer
4
Neoplasms
3
Prostate Cancer Metastatic
2
Metastatic Castration Resistant Prostate Cancer
2
Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Metastatic Castration-sensitive Prostate Cancer
1
Hyperaldosteronism
1
Castration-resistant Prostate Cancer
1
Castrate-resistant Prostate Cancer
1
Adenocarcinoma
1
Interventions
Mitotane
4
Cisplatin
3
pembrolizumab
2
cixutumumab
2
Etoposide
2
Doxorubicin
2
Dichlorodiphenyldichloroethane
2
sodium thiosulfate
1
relacorilant
1
pegfilgrastim
1
milademetan
1
gossypol acetic acid
1
cabozantinib
1
avelumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Sunitinib
1
Streptozocin
1
Platinum
1
Nivolumab
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Fentanyl
1
Ethane
1
Cytoreduction Surgical Procedures
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adrenocortical Carcinoma
×
Abiraterone Acetate
×
Clear all
No trials found.